Lord, Abbett & Co’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-205,036
| Closed | -$9.2M | – | 576 |
|
2022
Q1 | $9.2M | Buy |
205,036
+46,226
| +29% | +$2.07M | 0.02% | 470 |
|
2021
Q4 | $6.81M | Sell |
158,810
-1,550
| -1% | -$66.4K | 0.02% | 529 |
|
2021
Q3 | $10.7M | Buy |
160,360
+62,260
| +63% | +$4.14M | 0.03% | 522 |
|
2021
Q2 | $7.19M | Sell |
98,100
-95,349
| -49% | -$6.99M | 0.02% | 578 |
|
2021
Q1 | $13.2M | Sell |
193,449
-24,227
| -11% | -$1.66M | 0.03% | 479 |
|
2020
Q4 | $14.6M | Buy |
217,676
+35,608
| +20% | +$2.39M | 0.04% | 465 |
|
2020
Q3 | $9.37M | Buy |
182,068
+21,129
| +13% | +$1.09M | 0.03% | 483 |
|
2020
Q2 | $6.07M | Buy |
160,939
+23,870
| +17% | +$900K | 0.02% | 551 |
|
2020
Q1 | $4.09M | Sell |
137,069
-41,127
| -23% | -$1.23M | 0.02% | 560 |
|
2019
Q4 | $6.13M | Buy |
+178,196
| New | +$6.13M | 0.02% | 581 |
|